Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
- PMID: 30104296
- DOI: 10.2337/dc18-0287
Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
Abstract
Objective: Diabetes mellitus (DM) increases the risk of infections, but the effect of better control has not been thoroughly investigated.
Research design and methods: With the use of English primary care data, average glycated hemoglobin (HbA1c) during 2008-2009 was estimated for 85,312 patients with DM ages 40-89 years. Infection rates during 2010-2015 compiled from primary care, linked hospital, and mortality records were estimated across 18 infection categories and further summarized as any requiring a prescription or hospitalization or as cause of death. Poisson regression was used to estimate adjusted incidence rate ratios (IRRs) by HbA1c categories across all DM, and type 1 and type 2 DM separately. IRRs also were compared with 153,341 age-sex-practice-matched controls without DM. Attributable fractions (AF%) among patients with DM were estimated for an optimal control scenario (HbA1c 6-7% [42-53 mmol/mol]).
Results: Long-term infection risk rose with increasing HbA1c for most outcomes. Compared with patients without DM, those with DM and optimal control (HbA1c 6-7% [42-53 mmol/mol], IRR 1.41 [95% CI 1.36-1.47]) and poor control (≥11% [97 mmol/mol], 4.70 [4.24-5.21]) had elevated hospitalization risks for infection. In patients with type 1 DM and poor control, this risk was even greater (IRR 8.47 [5.86-12.24]). Comparisons within patients with DM confirmed the risk of hospitalization with poor control (2.70 [2.43-3.00]) after adjustment for duration and other confounders. AF% of poor control were high for serious infections, particularly bone and joint (46%), endocarditis (26%), tuberculosis (24%), sepsis (21%), infection-related hospitalization (17%), and mortality (16%).
Conclusions: Poor glycemic control is powerfully associated with serious infections and should be a high priority.
© 2018 by the American Diabetes Association.
Similar articles
-
Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data.Diabetes Res Clin Pract. 2024 May;211:111641. doi: 10.1016/j.diabres.2024.111641. Epub 2024 Mar 26. Diabetes Res Clin Pract. 2024. PMID: 38548108
-
Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study.Diabetes Care. 2018 Mar;41(3):513-521. doi: 10.2337/dc17-2131. Epub 2018 Jan 12. Diabetes Care. 2018. PMID: 29330152
-
The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).Diabetes Care. 2019 Mar;42(3):416-426. doi: 10.2337/dc17-1144. Epub 2018 Aug 13. Diabetes Care. 2019. PMID: 30104301 Free PMC article.
-
Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2018 May 17;7(11):e007858. doi: 10.1161/JAHA.117.007858. J Am Heart Assoc. 2018. PMID: 29773578 Free PMC article.
-
[The role of metabolic control in diabetes mellitus].Versicherungsmedizin. 1997 Feb 1;49(1):4-7. Versicherungsmedizin. 1997. PMID: 9133032 Review. German.
Cited by
-
Spatio-temporal modeling of COVID-19 prevalence and mortality using artificial neural network algorithms.Spat Spatiotemporal Epidemiol. 2022 Feb;40:100471. doi: 10.1016/j.sste.2021.100471. Epub 2021 Nov 11. Spat Spatiotemporal Epidemiol. 2022. PMID: 35120681 Free PMC article.
-
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.J Clin Virol. 2020 Jun;127:104354. doi: 10.1016/j.jcv.2020.104354. Epub 2020 Apr 9. J Clin Virol. 2020. PMID: 32305882 Free PMC article.
-
Childhood Vaccinations and Type 1 Diabetes.Front Immunol. 2021 Aug 26;12:667889. doi: 10.3389/fimmu.2021.667889. eCollection 2021. Front Immunol. 2021. PMID: 34512622 Free PMC article. Review.
-
The Role of Glucocorticoids in the Management of COVID-19.Horm Metab Res. 2021 Jan;53(1):9-15. doi: 10.1055/a-1300-2550. Epub 2020 Nov 18. Horm Metab Res. 2021. PMID: 33207372 Free PMC article. Review.
-
Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress.PeerJ. 2021 Feb 4;9:e10776. doi: 10.7717/peerj.10776. eCollection 2021. PeerJ. 2021. PMID: 33604180 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous